1999 to 2020 Saw Decline in Menopausal Hormone Therapy Use
By Elana Gotkine HealthDay Reporter
MONDAY, Sept. 30, 2024 -- From 1999 to 2020, there was a decrease in menopausal hormone therapy (MHT) use among postmenopausal women, according to a study published online Sept. 27 in JAMA Health Forum.
Lin Yang, Ph.D., from Cancer Care Alberta in Calgary, Canada, and colleagues examined trends in and correlates of MHT use among postmenopausal women in the United States using data from the nationally representative National Health and Nutrition Examination Survey from 1999 to March 2020. Data were analyzed for 13,048 U.S. postmenopausal women.
The researchers found that the prevalence of MHT use decreased among women of all ages from 26.9 to 4.7 percent in 1999 and 2020, respectively. MHT use was higher among women aged 52 to 65 years until 2002; since 2005, MHT use has been higher among those aged younger than 52 years. For women aged younger than 52 years, 52 to younger than 65 years, and 65 years and older, MHT use decreased by 23.5, 31.4, and 10.6 percent, respectively. Decreases in prevalence of MHT use were seen for Hispanic women (13.8 to 2.6 percent), non-Hispanic Black women (11.9 to 0.5 percent), and non-Hispanic White women (31.4 to 5.8 percent); prevalence was consistently highest for non-Hispanic White women. Among all racial and ethnic groups, the prevalence of MHT use varied by family income-to-poverty ratio and health insurance coverage.
"Discussions and policy on MHT use need to take into consideration sociodemographic factors such as age, race and ethnicity, income, and education," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted September 2024
Read this next
Plant-Based Diet Tied to Weight Loss, Fewer Hot Flashes in Postmenopausal Women
THURSDAY, June 5, 2025 -- A plant-based diet rich in soy, regardless of the level of processing, may benefit both hot flash and weight management in postmenopausal women...
ASCO: Elinzanetant Cuts Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
TUESDAY, June 3, 2025 -- For women with moderate-to-severe vasomotor symptoms associated with endocrine therapy for hormone receptor (HR)-positive breast cancer, elinzanetant, a...
Earlier Natural Menopause Risk Increased for Women in Socially Vulnerable Neighborhoods
THURSDAY, May 29, 2025 -- Women residing in U.S. neighborhoods with high social vulnerability have a higher risk for earlier natural menopause, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.